Literature DB >> 15144932

Cardiac remodeling in coronary artery disease.

Norman Sharpe1.   

Abstract

Cardiac remodeling is a central mechanism of heart failure progression in patients with coronary artery disease (CAD). The remodeling effect of beta-blockade with carvedilol has been studied in patients with left ventricular dysfunction after myocardial infarction and in patients with chronic heart failure of ischemic etiology. Carvedilol has been found to prevent progressive adverse ventricular remodeling in both conditions. This effect is concordant with the improvement in long-term clinical outcomes established for carvedilol in such patients. Thus, ventricular remodeling appears to be an important treatment target in patients with CAD and is likely to mediate at least part of the clinical improvement achieved with carvedilol.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15144932     DOI： 10.1016/j.amjcard.2004.01.002

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  6 in total

Review 1.  Mesenchymal stem cells for the treatment of heart failure.

Authors:  Shunsuke Ohnishi; Hajime Ohgushi; Soichiro Kitamura; Noritoshi Nagaya
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

Review 2.  Cell-based therapies for cardiac disease: a cellular therapist's perspective.

Authors:  Pampee P Young; Richard Schäfer
Journal:  Transfusion       Date:  2014-08-22       Impact factor: 3.157

3.  Ischemic cardiac tissue conditioned media induced differentiation of human mesenchymal stem cells into early stage cardiomyocytes.

Authors:  Balasundari Ramesh; Dillip Kumar Bishi; Suneel Rallapalli; Sarasabarathi Arumugam; Kotturathu Mammen Cherian; Soma Guhathakurta
Journal:  Cytotechnology       Date:  2012-03-07       Impact factor: 2.058

4.  Identification of a pro-angiogenic functional role for FSP1-positive fibroblast subtype in wound healing.

Authors:  Sarika Saraswati; Stephanie M W Marrow; Lester A Watch; Pampee P Young
Journal:  Nat Commun       Date:  2019-07-09       Impact factor: 14.919

5.  Plasma metabolomics provides new insights into the relationship between metabolites and outcomes and left ventricular remodeling of coronary artery disease.

Authors:  Qian Zhu; Min Qin; Zixian Wang; Yonglin Wu; Xiaoping Chen; Chen Liu; Qilin Ma; Yibin Liu; Weihua Lai; Hui Chen; Jingjing Cai; Yemao Liu; Fang Lei; Bin Zhang; Shuyao Zhang; Guodong He; Hanping Li; Mingliang Zhang; Hui Zheng; Jiyan Chen; Min Huang; Shilong Zhong
Journal:  Cell Biosci       Date:  2022-10-14       Impact factor: 9.584

6.  Ischemic patterns assessed by positron emission tomography predict adverse outcome in patients with idiopathic dilated cardiomyopathy.

Authors:  Richard M de Jong; Rene A Tio; Pim van der Harst; Adriaan A Voors; Paul M Koning; Clark J A M Zeebregts; Dirk J van Veldhuisen; Rudi A J O Dierckx; Riemer H J A Slart
Journal:  J Nucl Cardiol       Date:  2009-08-01       Impact factor: 5.952
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.